Psychedelic Commons
ExploreMethodsAbout
Share your data

Demyttenaere K

https://ror.org/05f950310University Psychiatric Centre KULeuven, Campus Leuven, Belgium.

5 papers · ORCID

View
ArticleKetamine

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Young AH, Bartova L, Cardoner N +9

Europe PMC2026
View
ArticleKetamine

Improvements in Functioning with Esketamine Nasal Spray versus Quetiapine Extended Release in Patients with Treatment Resistant Depression

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
View
ArticleKetamine

Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD

Young A, Godinov Y, Rive B +8

Europe PMC2025
View
ArticleKetamine

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
View
ArticleKetamine

Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.

McIntyre RS, Alsuwaidan M, Baune BT +24

Europe PMC2023
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.